News
Why mRNA Vaccines Are So Revolutionary—And What's at Stake If We Lose Them
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move rooted in a fundamental misunderstanding of vaccinology,” wrote Jake Scott, an infectious diseases specialist and clinical associate professor of medicine at Stanford University, on the social media site Bluesky.
Opinion
RFK Jr.’s slander of mRNA technology will harm Americans
Robert F. Kennedy Jr.’s decision to cancel almost $500 million in contracts for projects to develop vaccines using mRNA technology underscores perhaps the greatest harm that he might inflict on the nation with his anti-vaccine ideology.
ZME Science on MSN2d
This mRNA HIV Vaccine Produces the Virus-Fighting Antibodies That Have Eluded Researchers for 40 Years
In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
This includes terminating awards and contracts with pharmaceutical companies and universities and canceling 22 investment ...
The massive cuts by the Trump administration’s point man for destroying public health would dismantle a lifesaving technology ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
Live Science on MSN7d
Experimental HIV vaccines show promise in early safety test
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
Former Surgeon General Jerome Adams, who served under Trump’s first administration, criticized Kennedy’s move to cancel $500 million for mRNA projects. Adams said in a post on social media platform X ...
The Phase 1 trial will involve 56 healthy, HIV-negative adult participants. The company will give 48 of those individuals the mRNA vaccine. Thirty-two of that group will also receive the booster ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback